...
首页> 外文期刊>The Journal of dermatology >Successful treatment of diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells and basic fibroblast growth factor.
【24h】

Successful treatment of diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells and basic fibroblast growth factor.

机译:通过局部应用外周血单核细胞和碱性成纤维细胞生长因子的混合物成功治疗糖尿病性坏疽。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Diabetic gangrene is a non-healing skin ulcer that is often resistant to most common treatments. It is caused by microvascular disorders and an immunocompromised state which are induced by diabetes mellitus. We report a 65-year-old man with an aggressive, refractory diabetic gangrene on his left foot. Treatment of his diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells (PBMC) and basic fibroblast growth factor (bFGF) resulted in a dramatic improvement in a short time. The ulcer was completely closed and, in the past 6 months, no new ulceration has been observed. The patient is able to stand and walk by himself. Topical application of a mixture of PBMC and bFGF appears to be a useful, non-invasive and convenient method for the treatment of diabetic gangrene.
机译:糖尿病性坏疽是一种无法治愈的皮肤溃疡,通常对大多数常见疗法都有抵抗力。它是由糖尿病引起的微血管疾病和免疫功能低下引起的。我们报告了一个65岁的男子,左脚患有侵略性难治性糖尿病性坏疽。通过局部应用外周血单核细胞(PBMC)和碱性成纤维细胞生长因子(bFGF)的混合物治疗他的糖尿病性坏疽,在短时间内得到了显着改善。溃疡完全闭合,在过去的六个月中,未观察到新的溃疡。病人能够自己站立和行走。 PBMC和bFGF混合物的局部应用似乎是治疗糖尿病性坏疽的有用,无创且方便的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号